Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/2012
05/02/2012CN102429960A Weight-reducing decoction
05/02/2012CN102429957A Compound mustard flower oil pills
05/02/2012CN102429928A Preparation method for coix seed red yeast rice
05/02/2012CN102429920A Multi-associative hematic acid reducing composition and preparation method thereof
05/02/2012CN102429919A Water-soluble vitamin combination medicine
05/02/2012CN102429916A Substances mixture, use and infusion solution
05/02/2012CN102429911A Application of ZSTK474 to preparation of medicine for treating autoimmune diseases
05/02/2012CN102429908A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
05/02/2012CN102429906A Use of nitrogen heterocyclic compound in preparing drug for inhibiting toxicity of amyloid polypeptide
05/02/2012CN102429902A Pharmaceutical composition of alanyl glutamine and compound amino acid
05/02/2012CN102429891A Method for preparing low-molecular-weight sheep bone collagen polypeptide calcium chelate microcapsules
05/02/2012CN102429887A Sodium-potassium citrate chewing tablet and preparation method thereof
05/02/2012CN102429878A Calcium folinate for injection and production technology for calcium folinate
05/02/2012CN102429876A Liraglutide sustained-release microsphere preparation and preparation method thereof
05/02/2012CN102429865A Preparation method of super-micro molecular iron dextran
05/02/2012CN102429864A Medicinal compound of fat-soluble vitamin injection (II) and water-soluble vitamin for injection and preparation method thereof
05/02/2012CN102429851A Blood-circulation-promoting, weight-reducing and fat-lowering bath vinegar combining vinegar and traditional Chinese medicines and preparation method thereof
05/02/2012CN102429830A Method for extracting biological active peptide from animal placenta
05/02/2012CN102429825A Natural biomineralization powder, preparation method thereof and application thereof
05/02/2012CN102429055A Weight reducing tea
05/02/2012CN102428832A Fungal pharmaceutical mycoplasm with blood sugar lowering efficacy and preparation method thereof
05/02/2012CN102038720B Fuscoporia obliqua active ingredients capable of lowering blood sugar and preparation method and application of fuscoporia obliqua active ingredients
05/02/2012CN102000242B Medicine for treating chronic disease associated malnutrition and application thereof
05/02/2012CN101972260B Rosuvastatin calcium oral drug composition
05/02/2012CN101959522B Ketone accumulation inhibitor
05/02/2012CN101912491B Pills for treating cardiovascular diseases and preparation method
05/02/2012CN101869605B Method for extracting and separating mulberry leaf flavone and alkaloid composite
05/02/2012CN101829194B Composition for curing II-type diabetes mellitus and preparation method thereof
05/02/2012CN101808642B Mast cell stabilizers in the treatment of obesity
05/02/2012CN101804141B Chinese medicine compound for preventing and curing hypertension, hyperlipidemia, hyperglycemia and complications thereof
05/02/2012CN101804068B Polyethylene glycol-electrolyte oral solution
05/02/2012CN101757056B Extract of yangtao actinidia root and preparation method and applications thereof
05/02/2012CN101732395B Medicine or health-care food composition with function of regulating immunity, preparation method and application thereof
05/02/2012CN101671346B Lindenrane-type dimerization sesquiterpenoids, preparation method and applications thereof in pharmacy
05/02/2012CN101574476B Medicinal material composition used for lowering lipid and protecting liver auxiliarily
05/02/2012CN101558870B Mulberry and sea backthern concentrated food
05/02/2012CN101555241B Ampelopsin pro-dug and preparing method and application thereof
05/02/2012CN101502536B Cedar total flavone as well as preparation method and medical use
05/02/2012CN101480415B Cordyceps sinensis sustained and controlled release capsule and preparation method thereof
05/02/2012CN101474367B Pharmaceutical composition for reducing blood sugar
05/02/2012CN101273745B Health care tea for moistening intestines
05/01/2012US8168827 Amide derivative
05/01/2012US8168637 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment of diabetes
05/01/2012US8168616 Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
05/01/2012US8168587 Combination enzyme replacement and small molecule therapy for treatment of lysosomal storage diseases
05/01/2012US8168198 Therapeutic agent for polycystic ovary syndrome (PCOS)
05/01/2012US8168189 Protein A compositions and methods of use
05/01/2012CA2543507C Use of ghrelin and unacylated ghrelin compositions in insulin-related disease conditions
05/01/2012CA2490722C Novel benzimidazole derivatives
05/01/2012CA2473566C Pim-3 kinase as a target for type 2 diabetes mellitus
05/01/2012CA2437579C Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester
05/01/2012CA2429625C Hematopoietic cell e-selectin/l-selectin ligand polypeptides and methods of use thereof
04/2012
04/26/2012WO2012054920A2 Antigen-specific, tolerance-inducing microparticles and uses thereof
04/26/2012WO2012054535A2 Compounds, compositions and methods useful for cholesterol mobilisation
04/26/2012WO2012054530A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054528A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054527A2 Chemosensory receptor ligand-based therapies
04/26/2012WO2012054376A2 Metal ion nanoclusters
04/26/2012WO2012053667A1 USE OF β-GLUCAN DELAYING THE BIOSYNTHESIS OF YEAST AND MOLD UNDER ANAEROBIC CONDITION
04/26/2012WO2012053003A1 A novel herbal oil for controlling blood sugar without risk of hypoglycemea
04/26/2012WO2012052730A1 Use of pi3k inibitors for the treatment of obesity, steatosis and ageing
04/26/2012WO2012052595A1 Bicyclic aminocyclitols and use thereof for the treatment of lysosomal diseases
04/26/2012WO2012052555A1 Formulation comprising arginine, use and preparation thereof
04/26/2012WO2012052463A1 Cysteine and food intake
04/26/2012WO2012052372A1 Tetrahydroquinoline derivatives used as ampk activators
04/26/2012WO2012021249A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of histidyl-trna synthetases
04/26/2012WO2012021247A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glycyl-trna synthetases
04/26/2012WO2012009289A3 Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-trna synthetases
04/26/2012WO2011160093A3 Methods and systems for modulating hormones and related methods, agents and compositions
04/26/2012WO2011152658A3 Pharmaceutical composition comprising piperazine dithioctate and glimepiride
04/26/2012WO2011058474A8 N1-pyrazolospiroketone acetyl-coa carboxylase inhibitors
04/26/2012US20120101161 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders
04/26/2012US20120101150 Use of vgii3 activity modulator for the modulation of adipogenesis
04/26/2012US20120101149 Betulinic Acid Derivatives and Methods of Use Thereof
04/26/2012US20120101137 Novel thiophenecarboxamide derivative and pharmaceutical use thereof
04/26/2012US20120101136 5-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonists
04/26/2012US20120101134 5-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonists
04/26/2012US20120101127 Novel tetrahydroquinoline derivatives
04/26/2012US20120101124 1,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonists
04/26/2012US20120101123 Compounds
04/26/2012US20120101112 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/26/2012US20120101107 Piperazine dithioctate and pharmaceutical composition comprising the same
04/26/2012US20120101106 Tetrahydronapthyridine Orexin Receptor Antagonists
04/26/2012US20120101090 Crystal of a benzoxazinone compound
04/26/2012US20120101086 Thiadiazole derivatives and their use for the treatment of disorders mediated by s1p1 receptors
04/26/2012US20120101083 S1p1 agonists comprising a bicyclic n-containing ring
04/26/2012US20120101082 Vasopressin v1a antagonists
04/26/2012US20120101067 Methods for enhancing hematopoietic progenitor cell engraftment
04/26/2012US20120101062 Lipase Inhibitors
04/26/2012US20120101059 Sulphated hyaluronic acids as regulator agents of the cytokine activity
04/26/2012US20120101058 Pharmaceutical Composition For Prevention Or Treatment Of Lifestyle-Related Disease, And Food Useful For Prevention Or Treatment Of Lifestyle-Related Disease
04/26/2012US20120101051 Novel c-aryl glucoside sglt2 inhibitors and pharmaceutical compositions comprising same
04/26/2012US20120101039 Calcium-sensing receptor-active compounds
04/26/2012US20120101037 Glucose-dependent insulinotropic peptide analogs
04/26/2012US20120101030 Caspofungin Composition
04/26/2012US20120100235 Papaya puree and uses thereof
04/26/2012US20120100233 Compositions for treatment and prevention of diabetic complications using osteomeles schwerinae
04/26/2012US20120100228 Chromium complexes as enhancers of brain glucose transporters
04/26/2012US20120100226 Preventive remedial therapeutic agent for phosphorus impairment, oral agent for adsorbing phosphate ion contained in food, beverage and chemical, and process for producing them
04/26/2012US20120100216 Matrix carrier compositions, methods and uses
1 ... 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 ... 1298